| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH4 ABCA2 ATP7A HYOU1 ATRX SMC1A KIF1B ZNFX1 ACSF2 ABCB9 MACF1 DDX53 DDX24 ATP2B4 | 3.55e-05 | 614 | 143 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | 4.27e-05 | 230 | 143 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | nitrite reductase activity | 5.69e-05 | 11 | 143 | 3 | GO:0098809 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors | 2.27e-04 | 17 | 143 | 3 | GO:0016661 | |
| GeneOntologyMolecularFunction | pantothenate kinase activity | 3.03e-04 | 4 | 143 | 2 | GO:0004594 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 ABCA2 ATP7A ATRX SMC1A KIF1B ABCB9 MACF1 DDX53 DDX24 ATP2B4 | 3.41e-04 | 441 | 143 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | proteasome binding | 3.75e-04 | 20 | 143 | 3 | GO:0070628 | |
| GeneOntologyCellularComponent | axonemal central pair projection | 4.26e-05 | 2 | 137 | 2 | GO:1990718 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 3.87e-04 | 22 | 137 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | somatodendritic compartment | FLNB ATP7A ANK3 RASGRF1 MAP6 WFS1 PCLO KIF1B ANKS1B CYGB SRR CLSTN1 CASK TXNRD1 SLC32A1 MET CLCN2 SACS CPEB1 | 4.19e-04 | 1228 | 137 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | cone cell pedicle | 4.21e-04 | 5 | 137 | 2 | GO:0044316 | |
| GeneOntologyCellularComponent | dendrite | ATP7A ANK3 RASGRF1 MAP6 WFS1 PCLO KIF1B ANKS1B CLSTN1 CASK SLC32A1 MET CLCN2 SACS CPEB1 | 5.14e-04 | 858 | 137 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ATP7A ANK3 RASGRF1 MAP6 WFS1 PCLO KIF1B ANKS1B CLSTN1 CASK SLC32A1 MET CLCN2 SACS CPEB1 | 5.26e-04 | 860 | 137 | 15 | GO:0097447 |
| GeneOntologyCellularComponent | axonemal central apparatus | 6.29e-04 | 6 | 137 | 2 | GO:1990716 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 9.31e-04 | 114 | 137 | 5 | GO:0005798 | |
| Domain | ANKS1 | 5.66e-05 | 2 | 141 | 2 | IPR033635 | |
| Domain | Myoglobin | 5.66e-05 | 2 | 141 | 2 | IPR002335 | |
| Domain | IQ | 7.40e-05 | 93 | 141 | 6 | PS50096 | |
| Domain | - | 1.14e-04 | 13 | 141 | 3 | 1.10.490.10 | |
| Domain | Globin/Proto | 1.14e-04 | 13 | 141 | 3 | IPR012292 | |
| Domain | RNaseH-like_dom | 1.74e-04 | 69 | 141 | 5 | IPR012337 | |
| Domain | - | 3.36e-04 | 4 | 141 | 2 | 3.90.1460.10 | |
| Domain | Myc_N | 3.36e-04 | 4 | 141 | 2 | PF01056 | |
| Domain | Type_II_PanK | 3.36e-04 | 4 | 141 | 2 | IPR004567 | |
| Domain | Tscrpt_reg_Myc_N | 3.36e-04 | 4 | 141 | 2 | IPR012682 | |
| Domain | Tscrpt_reg_Myc | 3.36e-04 | 4 | 141 | 2 | IPR002418 | |
| Domain | Fumble | 3.36e-04 | 4 | 141 | 2 | PF03630 | |
| Domain | GTF2I | 3.36e-04 | 4 | 141 | 2 | PS51139 | |
| Domain | GTF2I | 3.36e-04 | 4 | 141 | 2 | PF02946 | |
| Domain | GTF2I | 3.36e-04 | 4 | 141 | 2 | IPR004212 | |
| Domain | IQ | 3.69e-04 | 81 | 141 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 6.00e-04 | 90 | 141 | 5 | IPR000048 | |
| Domain | P-loop_NTPase | RAB12 MYH1 MYH4 ABCA2 SAMD9 ATRX SMC1A KIF1B APAF1 ZNFX1 CASK ABCB9 DDX53 DDX24 HYDIN ARL14 | 6.76e-04 | 848 | 141 | 16 | IPR027417 |
| Pubmed | GABRB2 FLNB ANK3 MAP6 WFS1 PCLO UBR4 NACA ANKS1B ZNFX1 BIRC6 LIN7A SACM1L MET CADPS CYB5R3 MACF1 PIP4K2B UQCRC2 CRYBG3 FERMT2 RASAL1 | 1.98e-09 | 1139 | 144 | 22 | 36417873 | |
| Pubmed | ATP7A HYOU1 ANK3 ATRX WFS1 AHCTF1 UBR4 APAF1 FASTKD2 IKBIP CASK MRPL39 MET SACS EPHA2 MACF1 ERP29 UQCRC2 CRYBG3 FERMT2 DDX24 ATP2B4 EDRF1 SNX5 | 1.12e-08 | 1487 | 144 | 24 | 33957083 | |
| Pubmed | FLNB HYOU1 ANK3 MAP6 DOCK8 WFS1 PCLO KIF1B ANKS1B ZNFX1 SACM1L CASK CERS5 GUCY1A2 SACS CADPS MACF1 MCAT UQCRC2 FERMT2 ATP2B4 HCK RASAL1 | 2.54e-08 | 1431 | 144 | 23 | 37142655 | |
| Pubmed | RAB12 FLNB RIOK1 ATP7A HYOU1 ANK3 SMC1A AHCTF1 KIF1B ECPAS EPHA2 CYB5R3 MACF1 CRYBG3 FERMT2 ANKS1A | 4.53e-08 | 708 | 144 | 16 | 39231216 | |
| Pubmed | MYH1 FLNB MYH4 HYOU1 ATRX NSD2 PCLO MB UBR4 ANKS1B ATP5MK FER1L6 GTF2IRD2B ABCB9 GUCY1A2 SACS CYB5R3 GTF2IRD2 MACF1 PIP4K2B UQCRC2 CFAP69 | 1.31e-07 | 1442 | 144 | 22 | 35575683 | |
| Pubmed | 2.73e-07 | 14 | 144 | 4 | 21071677 | ||
| Pubmed | FLNB ABCA2 ANK3 ATRX KDM4C SMC1A KIF1B UBR4 NAP1L2 ANKS1B ZNFX1 CASK NAA25 WIZ SACS CADPS MACF1 MIGA1 ZMYM4 SNX5 | 3.78e-07 | 1285 | 144 | 20 | 35914814 | |
| Pubmed | RIOK1 SAMD9 HYOU1 ATRX RPS6KB1 NACA ZNFX1 CLSTN1 SACM1L ZNF638 UQCRC2 CRYBG3 IQGAP3 CWF19L1 | 5.85e-07 | 650 | 144 | 14 | 38777146 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | FLNB AHCTF1 PCLO UBR4 APAF1 ECPAS CASK SACS CADPS MACF1 FERMT2 ANKS1A | 1.22e-06 | 498 | 144 | 12 | 36634849 |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 20100865 | ||
| Pubmed | 3.83e-06 | 8 | 144 | 3 | 26993635 | ||
| Pubmed | 3.83e-06 | 8 | 144 | 3 | 12037680 | ||
| Pubmed | ATRX SMC1A AHCTF1 BIRC6 IKBIP KMT2C NFKB1 ZNF638 HYDIN ZMYM4 ANKS1A | 4.47e-06 | 469 | 144 | 11 | 27634302 | |
| Pubmed | TDRD15 ATP7A ANK3 KIF1B BIRC6 CASK MET WIZ EPHA2 CYB5R3 ZNF638 MIEF1 FERMT2 ARL14 | 4.66e-06 | 777 | 144 | 14 | 35844135 | |
| Pubmed | 8.17e-06 | 10 | 144 | 3 | 28361920 | ||
| Pubmed | MYC MYCL ESRRB KIF1B GRHL2 BIRC6 CERS5 MET KMT2C KLHL9 NFKB1 ZNF638 MACF1 | 8.60e-06 | 709 | 144 | 13 | 22988430 | |
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.12e-05 | 11 | 144 | 3 | 16024798 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.12e-05 | 11 | 144 | 3 | 38303699 | |
| Pubmed | 1.17e-05 | 335 | 144 | 9 | 15741177 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB ANK3 ATRX NSD2 RPS6KB1 KIF1B ECPAS GRHL2 LRRC8D DENND2B CASK KMT2C KLHL9 PCNX4 ZNF638 MACF1 CFAP69 ZMYM4 ANKS1A | 1.33e-05 | 1489 | 144 | 19 | 28611215 |
| Pubmed | 1.49e-05 | 263 | 144 | 8 | 34702444 | ||
| Pubmed | 1.50e-05 | 36 | 144 | 4 | 22421546 | ||
| Pubmed | Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase. | 1.70e-05 | 2 | 144 | 2 | 11968011 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 37301535 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 23821202 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 34257619 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31321444 | ||
| Pubmed | Solution structure of the first Sam domain of Odin and binding studies with the EphA2 receptor. | 1.70e-05 | 2 | 144 | 2 | 22332920 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26008146 | ||
| Pubmed | Role of Periostin and Nuclear Factor-κB Interplay in the Development of Diabetic Nephropathy. | 1.70e-05 | 2 | 144 | 2 | 35883655 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 1.70e-05 | 2 | 144 | 2 | 9382868 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 11150240 | ||
| Pubmed | c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells. | 1.70e-05 | 2 | 144 | 2 | 28232371 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26100671 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28327142 | ||
| Pubmed | Peptide Fragments of Odin-Sam1: Conformational Analysis and Interaction Studies with EphA2-Sam. | 1.70e-05 | 2 | 144 | 2 | 26120079 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 37827180 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22172699 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 18566574 | ||
| Pubmed | UBR4/POE facilitates secretory trafficking to maintain circadian clock synchrony. | 1.70e-05 | 2 | 144 | 2 | 35332162 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 15738393 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 19433583 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12110687 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12783888 | ||
| Pubmed | MYCL promotes iPSC-like colony formation via MYC Box 0 and 2 domains. | 1.70e-05 | 2 | 144 | 2 | 34930932 | |
| Pubmed | A therapeutic approach to pantothenate kinase associated neurodegeneration. | 1.70e-05 | 2 | 144 | 2 | 30352999 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31784729 | ||
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 1.70e-05 | 2 | 144 | 2 | 15388857 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22645312 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 1.70e-05 | 2 | 144 | 2 | 11744674 | |
| Pubmed | SDK2 ATP7A HYOU1 AHCTF1 RPS6KB1 NACA IKBIP WIZ CYB5R3 MIEF1 ERP29 FERMT2 CWF19L1 ZMYM4 SNX5 | 2.01e-05 | 1007 | 144 | 15 | 34597346 | |
| Pubmed | 2.45e-05 | 14 | 144 | 3 | 27184118 | ||
| Pubmed | 2.85e-05 | 288 | 144 | 8 | 38496616 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB ABCA2 HYOU1 ANK3 PCLO RPS6KB1 UBR4 ECPAS TXNRD1 MACF1 ERP29 IQGAP3 HYDIN | 3.32e-05 | 807 | 144 | 13 | 30575818 |
| Pubmed | 3.74e-05 | 16 | 144 | 3 | 16494860 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.89e-05 | 220 | 144 | 7 | 35785414 | |
| Pubmed | 3.98e-05 | 150 | 144 | 6 | 32423001 | ||
| Pubmed | FLNB HYOU1 ANK3 ATRX MAP6 AHCTF1 RPS6KB1 IKBIP KMT2C UBE2R2 ZNF638 MACF1 ERP29 FERMT2 SNX5 | 4.66e-05 | 1084 | 144 | 15 | 11544199 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 5.09e-05 | 3 | 144 | 2 | 26059207 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28671819 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 36515178 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17379144 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 10486218 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 35046895 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 12511555 | ||
| Pubmed | Cytoglobin is a stress-responsive hemoprotein expressed in the developing and adult brain. | 5.09e-05 | 3 | 144 | 2 | 16899760 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 36433941 | ||
| Pubmed | Amino acid-dependent signaling via S6K1 and MYC is essential for regulation of rDNA transcription. | 5.09e-05 | 3 | 144 | 2 | 27385002 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 2470008 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 34958351 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17875921 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 25220053 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 38123547 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23106691 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 18059365 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23420891 | ||
| Pubmed | Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions. | 5.09e-05 | 3 | 144 | 2 | 29749928 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23178487 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 36995441 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 35343073 | ||
| Pubmed | EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer. | 5.09e-05 | 3 | 144 | 2 | 30451837 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 15100712 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 16688213 | ||
| Pubmed | Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo. | 5.09e-05 | 3 | 144 | 2 | 22884366 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 29650964 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 35017527 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17631502 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23152917 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 38031763 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 22020416 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17520086 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 12504005 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 7.22e-05 | 167 | 144 | 6 | 20362541 | |
| Pubmed | 7.59e-05 | 529 | 144 | 10 | 14621295 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYC MYH4 CYP4F8 HYOU1 ATRX SMC1A KIF1B UBR4 ECPAS MET KMT2C NAA25 PANK2 UQCRC2 DDX24 ANKS1A | 8.86e-05 | 1284 | 144 | 16 | 17353931 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB RIOK1 HYOU1 ATRX NSD2 SMC1A PCLO UBR4 NACA FASTKD2 ECPAS SACM1L CYB5R3 ERP29 UQCRC2 DDX24 IQGAP3 | 8.95e-05 | 1425 | 144 | 17 | 30948266 |
| Pubmed | FLNB HYOU1 NSD2 AHCTF1 UBR4 ECPAS BIRC6 ZNF638 MACF1 UQCRC2 DDX24 | 9.23e-05 | 653 | 144 | 11 | 22586326 | |
| Pubmed | TSPAN15 CAAP1 ATP7A HYOU1 ANK3 SMC1A RPS6KB1 KIF1B LIPF ANKS1B ZNF571 LRRC8D POSTN KMT2C ZNF638 HYDIN | 9.60e-05 | 1293 | 144 | 16 | 15342556 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 26085624 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 22815849 | ||
| Interaction | DNAJC5 interactions | ATP7A ANK3 LIN7A CASK SLC32A1 MET CADPS EPHA2 MACF1 FERMT2 ATP2B4 EDRF1 SNX5 | 3.08e-06 | 378 | 143 | 13 | int:DNAJC5 |
| Interaction | CASK interactions | 4.11e-06 | 221 | 143 | 10 | int:CASK | |
| Interaction | STAG3L4 interactions | 1.20e-05 | 7 | 143 | 3 | int:STAG3L4 | |
| Interaction | KCNA3 interactions | RAB12 FLNB RIOK1 ATP7A HYOU1 ANK3 SMC1A AHCTF1 KIF1B NACA ECPAS KMT2C EPHA2 CYB5R3 MACF1 CRYBG3 FERMT2 IQGAP3 ANKS1A | 1.32e-05 | 871 | 143 | 19 | int:KCNA3 |
| Interaction | GUCY1B1 interactions | 2.02e-05 | 47 | 143 | 5 | int:GUCY1B1 | |
| Cytoband | 12q23-q24.1 | 1.45e-04 | 6 | 144 | 2 | 12q23-q24.1 | |
| GeneFamily | Zinc fingers MYM-type | 4.48e-04 | 6 | 100 | 2 | 86 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC FLNB ATRX AVL9 KDM4C AHCTF1 DENND2B CASK TXNRD1 SACS NFKB1 ZNF638 MACF1 CRYBG3 FERMT2 ATP2B4 ZMYM4 IL7R ANKS1A | 2.50e-07 | 856 | 144 | 19 | M4500 |
| Coexpression | GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 1.55e-05 | 200 | 144 | 8 | M3271 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP | 1.55e-05 | 200 | 144 | 8 | M7135 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP | 1.55e-05 | 200 | 144 | 8 | M9060 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | GABRB2 ANK3 ATRX KIF1B APAF1 DTX3L ECPAS LGR5 CASK SPPL2A MIGA1 FERMT2 ZMYM4 | 1.34e-06 | 369 | 143 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | GABRB2 MYH1 HYOU1 AVL9 SLC38A4 APAF1 NAP1L2 IKBIP IGDCC4 CASK POSTN PIEZO2 CLCN2 HMCN1 CADPS SESN2 HCK ZMYM6 SENP7 | 1.57e-06 | 791 | 143 | 19 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | GABRB2 MYCL ANK3 ATRX KIF1B APAF1 NAP1L2 DTX3L ECPAS IFI16 LGR5 CASK ESRP2 SPPL2A TC2N HMCN1 MIGA1 FERMT2 ZMYM4 | 2.07e-06 | 806 | 143 | 19 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | RAB12 ATP7A ATRX SMC1A KIF1B LGR5 BIRC6 PANK1 TXNRD1 KATNBL1 CPEB1 | 9.24e-05 | 403 | 143 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | RAB12 ATP7A ATRX TLCD4 LGR5 BIRC6 PANK1 KMT2C KATNBL1 SPPL2A TC2N HMCN1 SACS ZMYM6 SENP7 CPEB1 | 9.32e-05 | 795 | 143 | 16 | gudmap_developingGonad_e16.5_ovary_1000 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.92e-08 | 200 | 144 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-07 | 179 | 144 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-07 | 186 | 144 | 8 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.27e-07 | 193 | 144 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.97e-07 | 200 | 144 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 175 | 144 | 7 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-06 | 177 | 144 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-06 | 177 | 144 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.81e-06 | 177 | 144 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-06 | 177 | 144 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.81e-06 | 177 | 144 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 187 | 144 | 7 | 08f2ecce3c08f35d995187b21bb7407a99dee4c2 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial-epithelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 187 | 144 | 7 | 939a068ac0913b9eeb5da4a9cb267d51cb711999 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 187 | 144 | 7 | e02e7f608506b9a48384f07727944f1cb8f7c575 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.70e-06 | 188 | 144 | 7 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-06 | 190 | 144 | 7 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 192 | 144 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.10e-06 | 192 | 144 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 193 | 144 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 193 | 144 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 3.43e-06 | 195 | 144 | 7 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-06 | 196 | 144 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | frontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.55e-06 | 196 | 144 | 7 | de7d10da862f98894ce47244fbc992f4a12d63bb | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.67e-06 | 197 | 144 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.80e-06 | 198 | 144 | 7 | b0b0977d9482538a076b84a8dc8b15ed682662f9 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.92e-06 | 199 | 144 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD4+_Tcm|COVID-19_Convalescent / Disease, condition lineage and cell class | 4.06e-06 | 200 | 144 | 7 | 99c5abfe96d791c60ae6021ab4201851ee4afc47 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 1.27e-05 | 158 | 144 | 6 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.27e-05 | 158 | 144 | 6 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 161 | 144 | 6 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 161 | 144 | 6 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 1.47e-05 | 162 | 144 | 6 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | COVID-19_Severe-CD4+_T_activated|COVID-19_Severe / Disease condition and Cell class | 1.69e-05 | 166 | 144 | 6 | 0f138dbafad6f83975944e8f6398411127b150cc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-05 | 167 | 144 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 1.93e-05 | 170 | 144 | 6 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 175 | 144 | 6 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 178 | 144 | 6 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 178 | 144 | 6 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.58e-05 | 179 | 144 | 6 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 179 | 144 | 6 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | ASK454-Epithelial-Ciliated|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.58e-05 | 179 | 144 | 6 | f21919ef9d3d984e2925ef3d24f89e20fe265dcd | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-05 | 179 | 144 | 6 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.75e-05 | 181 | 144 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-05 | 182 | 144 | 6 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 184 | 144 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 184 | 144 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 184 | 144 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 184 | 144 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-05 | 185 | 144 | 6 | e34473eea3a58c041183a4f52137366cd9489495 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 185 | 144 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.10e-05 | 185 | 144 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-05 | 186 | 144 | 6 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.20e-05 | 186 | 144 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.20e-05 | 186 | 144 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.20e-05 | 186 | 144 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.40e-05 | 188 | 144 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.40e-05 | 188 | 144 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 3.60e-05 | 190 | 144 | 6 | 5f8d606d2f465ddeae7451835f84b3f25a151d2a | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.60e-05 | 190 | 144 | 6 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.60e-05 | 190 | 144 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.60e-05 | 190 | 144 | 6 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.71e-05 | 191 | 144 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 191 | 144 | 6 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.71e-05 | 191 | 144 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-05 | 191 | 144 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.71e-05 | 191 | 144 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.71e-05 | 191 | 144 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-05 | 191 | 144 | 6 | 9c747f8cc1cdce45e839b661d782e1e8cfb79578 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.71e-05 | 191 | 144 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-05 | 191 | 144 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 191 | 144 | 6 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.71e-05 | 191 | 144 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 3.71e-05 | 191 | 144 | 6 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 3.82e-05 | 192 | 144 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-05 | 192 | 144 | 6 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-05 | 192 | 144 | 6 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.82e-05 | 192 | 144 | 6 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|World / disease group, cell group and cell class | 3.82e-05 | 192 | 144 | 6 | 3352f13a6e706991dcf3ec173587bb6aba36a385 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.82e-05 | 192 | 144 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 3.82e-05 | 192 | 144 | 6 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 192 | 144 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|World / disease group, cell group and cell class | 3.93e-05 | 193 | 144 | 6 | c2a2a2c14a7085690262db5c2a70e38db67dee18 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 193 | 144 | 6 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 193 | 144 | 6 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.93e-05 | 193 | 144 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.93e-05 | 193 | 144 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 193 | 144 | 6 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 193 | 144 | 6 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|COVID-19_Severe / disease group, cell group and cell class | 3.93e-05 | 193 | 144 | 6 | 45fe14c10b71459047608c8931d83c9c533f97f9 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-05 | 194 | 144 | 6 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.05e-05 | 194 | 144 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Severe-CD4+_T|World / Disease group and Cell class | 4.05e-05 | 194 | 144 | 6 | 2ad888f78765ecfb8d1ea978c75c90fa3030509a | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 194 | 144 | 6 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 4.05e-05 | 194 | 144 | 6 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.16e-05 | 195 | 144 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 195 | 144 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-05 | 195 | 144 | 6 | 06051de72b5c1e0d483a28b14dabd247dfca0ed9 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.16e-05 | 195 | 144 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-05 | 195 | 144 | 6 | 3aa44633c72658545aa2b35bf9d532c62f36a451 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.16e-05 | 195 | 144 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.92e-05 | 50 | 87 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | MYC ANK3 AVL9 SIDT1 NAP1L2 ZNF571 MET KLHL9 PIP4K2B ATP2B4 ZMYM6 | 3.04e-08 | 188 | 143 | 11 | 5691_DN |
| Drug | AC1N9ZZC | 4.37e-07 | 149 | 143 | 9 | CID004369374 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | HSPG2 FLNB NAP1L2 ANKS1B ST8SIA3 DENND2B IGDCC4 TXNRD1 SLC32A1 CADPS EPHA2 SESN2 CPEB1 | 6.99e-07 | 373 | 143 | 13 | ctd:C540355 |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 2.37e-05 | 186 | 143 | 8 | 1228_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.46e-05 | 187 | 143 | 8 | 1218_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; HL60; HT_HG-U133A | 3.32e-05 | 195 | 143 | 8 | 2355_DN | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; MCF7; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 5668_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 6095_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 1678_UP | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 3308_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 3575_DN | |
| Drug | SB 203580; Up 200; 1uM; MCF7; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 6915_UP | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; PC3; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 6645_DN | |
| Drug | l3 g | 3.92e-05 | 2 | 143 | 2 | CID009549185 | |
| Drug | Ketamine | MYC GABRB2 CAAP1 ATP7A RASGRF1 MAP6 WFS1 PANK1 DENND2B IKBIP SLC32A1 MSANTD3 KLHL9 CYB5R3 ZNF638 SENP7 | 4.32e-05 | 798 | 143 | 16 | ctd:D007649 |
| Disease | Neuroblastoma | 2.92e-06 | 47 | 140 | 5 | C0027819 | |
| Disease | Colorectal Carcinoma | MYC RPS6KB1 LGR5 TXNRD1 POSTN KMT2C GUCY1A2 SACS SESN2 UQCRC2 EDRF1 ZMYM4 IQUB | 3.16e-05 | 702 | 140 | 13 | C0009402 |
| Disease | myopathy (implicated_via_orthology) | 8.03e-05 | 48 | 140 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 8.32e-05 | 93 | 140 | 5 | C1535926 | |
| Disease | pantothenate kinase-associated neurodegeneration (implicated_via_orthology) | 1.33e-04 | 4 | 140 | 2 | DOID:3981 (implicated_via_orthology) | |
| Disease | sarcoma (is_marker_for) | 2.21e-04 | 5 | 140 | 2 | DOID:1115 (is_marker_for) | |
| Disease | Carcinoma, Granular Cell | 2.35e-04 | 116 | 140 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.35e-04 | 116 | 140 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.35e-04 | 116 | 140 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.35e-04 | 116 | 140 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.35e-04 | 116 | 140 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 2.35e-04 | 116 | 140 | 5 | C0001418 | |
| Disease | azoospermia (implicated_via_orthology) | 2.81e-04 | 27 | 140 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Hematopoetic Myelodysplasia | 3.49e-04 | 29 | 140 | 3 | C2713368 | |
| Disease | stem Cell Growth Factor beta measurement | 4.54e-04 | 75 | 140 | 4 | EFO_0008292 | |
| Disease | Colonic Neoplasms | 8.10e-04 | 152 | 140 | 5 | C0009375 | |
| Disease | calcium measurement | SLC38A4 SIDT1 DTX3L SPPL2A TC2N PCNX4 CYB5R3 MACF1 MIGA1 SENP7 | 8.58e-04 | 628 | 140 | 10 | EFO_0004838 |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Malignant tumor of colon | 9.91e-04 | 159 | 140 | 5 | C0007102 | |
| Disease | Secondary Biliary Cholangitis | 1.05e-03 | 42 | 140 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 1.05e-03 | 42 | 140 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 1.05e-03 | 42 | 140 | 3 | C4551595 | |
| Disease | autistic disorder (is_implicated_in) | 1.05e-03 | 42 | 140 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 1.05e-03 | 42 | 140 | 3 | DOID:612 (is_implicated_in) | |
| Disease | Childhood Medulloblastoma | 1.12e-03 | 43 | 140 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.12e-03 | 43 | 140 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 1.12e-03 | 43 | 140 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.12e-03 | 43 | 140 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 1.12e-03 | 43 | 140 | 3 | C0278876 | |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 1.20e-03 | 11 | 140 | 2 | EFO_0801494 | |
| Disease | trypsin-3 measurement | 1.20e-03 | 11 | 140 | 2 | EFO_0020791 | |
| Disease | biliary liver cirrhosis | 1.20e-03 | 44 | 140 | 3 | EFO_0004267 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.30e-03 | 169 | 140 | 5 | DOID:3908 (is_marker_for) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.43e-03 | 12 | 140 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.43e-03 | 12 | 140 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Primary biliary cirrhosis | 1.45e-03 | 47 | 140 | 3 | C0008312 | |
| Disease | venous thromboembolism | 1.64e-03 | 460 | 140 | 8 | EFO_0004286 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.68e-03 | 13 | 140 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Medulloblastoma | 1.74e-03 | 50 | 140 | 3 | C0025149 | |
| Disease | Colorectal Neoplasms | 2.13e-03 | 277 | 140 | 6 | C0009404 | |
| Disease | factor XI measurement, coronary artery disease | 2.23e-03 | 115 | 140 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | Yu-Zhi constitution type | 2.25e-03 | 15 | 140 | 2 | EFO_0007638 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.25e-03 | 15 | 140 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | third ventricle volume measurement | 2.25e-03 | 15 | 140 | 2 | EFO_0010335 | |
| Disease | phosphatidylcholine 38:6 measurement | 2.57e-03 | 16 | 140 | 2 | EFO_0010388 | |
| Disease | adverse effect, response to xenobiotic stimulus | 2.80e-03 | 59 | 140 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.08e-03 | 206 | 140 | 5 | C0152013 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.08e-03 | 61 | 140 | 3 | C1961102 | |
| Disease | Nuclear non-senile cataract | 3.25e-03 | 18 | 140 | 2 | C1112705 | |
| Disease | Nuclear cataract | 3.25e-03 | 18 | 140 | 2 | C0392557 | |
| Disease | Malignant Neoplasms | 3.29e-03 | 128 | 140 | 4 | C0006826 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.37e-03 | 63 | 140 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.63e-03 | 19 | 140 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.01e-03 | 67 | 140 | 3 | C3463824 | |
| Disease | Fetal Growth Retardation | 4.02e-03 | 20 | 140 | 2 | C0015934 | |
| Disease | lymphocyte count | MYCL FLNB KIF1B CLSTN1 GRHL2 CERS5 GTF2IRD2B SPPL2A LPAR6 NFKB1 GTF2IRD2 ZNF638 SESN2 ATP2B4 IL7R | 4.13e-03 | 1464 | 140 | 15 | EFO_0004587 |
| Disease | Benign Neoplasm | 4.18e-03 | 68 | 140 | 3 | C0086692 | |
| Disease | Neoplasms | 4.18e-03 | 68 | 140 | 3 | C0027651 | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.36e-03 | 69 | 140 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.41e-03 | 139 | 140 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Neoplastic Cell Transformation | 4.41e-03 | 139 | 140 | 4 | C0007621 | |
| Disease | Vertigo | 4.41e-03 | 139 | 140 | 4 | HP_0002321 | |
| Disease | periodontitis (biomarker_via_orthology) | 4.42e-03 | 21 | 140 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | Bladder Neoplasm | 4.52e-03 | 140 | 140 | 4 | C0005695 | |
| Disease | ascending aortic diameter | 4.52e-03 | 140 | 140 | 4 | EFO_0021787 | |
| Disease | bipolar I disorder | 4.64e-03 | 141 | 140 | 4 | EFO_0009963 | |
| Disease | Malignant neoplasm of urinary bladder | 4.64e-03 | 141 | 140 | 4 | C0005684 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.72e-03 | 71 | 140 | 3 | EFO_0001645, EFO_0004791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKIHVSPDFKTYVTV | 1221 | O14727 | |
| KPLSVLKSLEEKYVA | 4516 | Q9NR09 | |
| ASKVKSLKPIDYVFE | 2736 | Q68DQ2 | |
| DKKILFRYSVKVLTP | 1116 | Q8N7X0 | |
| LDTVTFYKVIPKSKF | 41 | P30040 | |
| KISHFKIPKYIVFVT | 576 | Q96CM8 | |
| YKLKLAKDITTIPTI | 31 | Q8N4G2 | |
| KKIPTIILSITYKGV | 976 | Q92625 | |
| VSLKPVSFYISDKKE | 131 | Q9H8G2 | |
| APVFKEKSYKATVIE | 161 | O94985 | |
| LFEYFVVVSLKKKPS | 696 | P78524 | |
| ILEKVFISITKYPDK | 91 | Q8N5B7 | |
| VKLVPSSSYIKVVKA | 1131 | P23634 | |
| LIEISPYKFQKGKDV | 146 | Q8TBG4 | |
| TLLKTKGVTDIKIYP | 106 | Q04656 | |
| KKPDFTTVKIVNYTV | 771 | Q8TDY8 | |
| VLKPVISRVFEEKKY | 366 | O95294 | |
| KGIILVYDITKKETF | 116 | Q6IQ22 | |
| VDLVIKVYFKDTHPK | 106 | P00387 | |
| YPFKPKLTIKTAFVI | 251 | Q9Y5X5 | |
| LDTDFVESLPVKVKY | 96 | Q9ULW6 | |
| LPTIKDAYRKFEIKI | 3676 | P98160 | |
| SRFYSLKVAPKVKAT | 11 | P22695 | |
| KLKTVLKYSPFVVSF | 391 | Q96DU7 | |
| FALESEIISKLYIPK | 396 | Q5JPF3 | |
| KVPTIILSVSYKGVK | 1101 | Q7Z6G8 | |
| FTVKAASKYVDVPKP | 1211 | Q9ULU8 | |
| VTYEEVVKLPAFKRK | 726 | O14936 | |
| PLVKSLLKSKFEEYV | 221 | Q9H079 | |
| PYCVSIKITKVVLSK | 986 | Q8NEZ4 | |
| KAAKDSVKLVVRYTP | 176 | O14910 | |
| KADIAVPLVFTKYSE | 21 | Q96JE9 | |
| IIKSVGELSVPEKYK | 566 | Q3B7T1 | |
| ITESFVDYIKTKPIV | 1176 | O60333 | |
| IVLYFKLRSKKTPAV | 41 | Q96IX5 | |
| HVKYKTFEIPVIKIE | 876 | O95786 | |
| YKTGIKKAPIQTYVL | 56 | Q69YN2 | |
| SVYPEKLATKFVDKT | 681 | Q5VYK3 | |
| PFKVKVLPTYDASKV | 1506 | O75369 | |
| AKYDLPATIDFIVKK | 146 | P07098 | |
| KVEIIKHISAPEKTY | 3546 | Q9Y6V0 | |
| TVKFLIPGKKYVANT | 126 | Q63HM2 | |
| IPTTIYKAKKIVSTI | 686 | Q9HCI6 | |
| CFTKRQYPETKIIKT | 1056 | O96028 | |
| PTAVIVFSYVKIIAK | 211 | Q6U736 | |
| VLKKYGIPFDKITQE | 251 | Q9H3R0 | |
| VGLKKIIDFIYTAKL | 101 | Q9P2J3 | |
| FTYVAPSVLESVKEK | 411 | P23443 | |
| SIVDYKLITKKVVFS | 211 | P47870 | |
| IYFIETKKFLLIGKS | 91 | P16871 | |
| IIKPAKYFSELEKSI | 6 | Q96H12 | |
| LAIVYPFKSKTLRTK | 116 | P43657 | |
| LYFKIKPLLKSAETE | 836 | P12882 | |
| YLSPKTVADTFEKVV | 256 | Q9NQG6 | |
| LKTVTFANDLKPKVY | 271 | Q70UQ0 | |
| YVAKVLKATLAEKFP | 1146 | Q86VI3 | |
| IVPYSELVKKCKIDI | 2631 | Q9UPN3 | |
| ELVKFLSVKYTTKQP | 111 | A6NCF6 | |
| KKFSLTVYVPPSIKD | 3046 | Q96RW7 | |
| TLVKLVYFEPKDITA | 221 | Q9BZ23 | |
| KAVDIKKPLVSVYSN | 286 | Q8IVS2 | |
| SQKEEKKIILTYFAP | 261 | Q7Z6J6 | |
| KVTKELYVKLTPVSL | 581 | P46100 | |
| LSKAFKVKPFVVRDA | 426 | Q9Y4L1 | |
| KLVKLHAVVTKEPIY | 316 | P08631 | |
| LVKVVEESSPYFKVI | 131 | Q4G0P3 | |
| AIPLQKKSDITYFKT | 456 | Q6ISB3 | |
| DFYEEVKIKLPAKLT | 626 | Q8NF50 | |
| KISEAFVKIPVKLFA | 356 | Q8TDB6 | |
| VPVAIKTLKAGYTEK | 641 | P29317 | |
| EKKVLFYISPVNKLV | 201 | Q8NBF6 | |
| KHKVEPVYFKILSGV | 116 | Q8WWM9 | |
| AITDKDIVFYKTLKP | 116 | P98187 | |
| LPLVVCVDKLTKVYK | 986 | Q9BZC7 | |
| VKSPSKKVLYREYVV | 2921 | Q12955 | |
| RKLKTAPSYIKDVII | 296 | Q5I0G3 | |
| KIFPGKKSVVSEYVA | 241 | O75342 | |
| KEKFTPKKIIAIANY | 621 | Q16666 | |
| IPFKVDTILKYLKDH | 146 | Q8NA54 | |
| IGPEDVINFKKIYKT | 691 | Q9GZR7 | |
| LPPVKKNFYIESKAT | 171 | Q86TM3 | |
| KTTKFTKKVQIDPYL | 496 | Q9BZB8 | |
| VYEGKIFTQKSKVPV | 1416 | Q8WYP5 | |
| KKPLTKIVSYLLVAE | 206 | O95718 | |
| SIPELADYIKVFKPK | 371 | Q96AC1 | |
| TVLKTKYDKVGIPEF | 876 | Q86UP8 | |
| TVLKTKYDKVGIPEF | 876 | Q6EKJ0 | |
| KVILALFTYVKKPEK | 391 | A5D8W1 | |
| ILIKDIPKEVSSYTF | 1871 | Q58EX2 | |
| YLIVITKKIKVGEFF | 71 | Q9NTJ5 | |
| VVKDTLKKFLSFFPV | 2951 | Q9NZJ4 | |
| KLYVVQTVIKTAKFI | 306 | Q7L1W4 | |
| KFETKAPFSSLKVII | 671 | O75473 | |
| TLVKLVYFEPKDITA | 246 | Q8TE04 | |
| EKKKTVDLLYSIFPG | 486 | P33402 | |
| KEPTIKFYTKQILEG | 746 | Q6ZN16 | |
| YSLSQIKFSPVAKKL | 61 | Q8NAN2 | |
| IKFSPVAKKLFVVTA | 66 | Q8NAN2 | |
| KSDPYIVIKLGKTEI | 1376 | Q2WGJ9 | |
| YTLVITGKKITKIPL | 501 | P08581 | |
| AIKIYKTSILVFKDR | 206 | Q9BRS2 | |
| LKVYIKTVACYPEKT | 421 | P58004 | |
| YKPLTKSCEIKFLTF | 116 | Q9NYK5 | |
| TITKKYIKIPFQVSL | 541 | Q9BQF6 | |
| KEVPFVVPKFKLSYI | 71 | Q8N9U0 | |
| AIPSIYVKKLKQDFI | 331 | B5MCY1 | |
| TAIAKKYIRYEKPLV | 816 | Q5K651 | |
| PKVVILKKATAYILS | 391 | P01106 | |
| VTFLKTKIYSVEALP | 686 | Q9NYY8 | |
| AIIDILTPYDTKKKA | 366 | P78356 | |
| VSLKKENIFTTPKYA | 31 | O43173 | |
| LYFKIKPLLKSAETE | 836 | Q9Y623 | |
| AKTYIQTELPFKAKT | 1371 | O95785 | |
| TVKALKPSVKVYAAE | 196 | Q9GZT4 | |
| LFSKPEVIKQKYETG | 221 | Q9H6T0 | |
| VFYLKLVKKETFRSP | 496 | Q969I6 | |
| VVLDKLITIYKKPIS | 686 | Q13972 | |
| KLLSYTKPDVAFLVA | 176 | Q9NP78 | |
| IPTKIIKYDILTKSS | 431 | Q9HAY6 | |
| LKEYLTLKTFIAKVI | 176 | P51788 | |
| EVKKLFKSLCVPYFV | 81 | Q16881 | |
| VKVPTTLAEYCVKTK | 181 | P49427 | |
| KAPKVVILSKALEYL | 316 | P12524 | |
| LKKTKTSEYPIIFVY | 41 | Q5MJ09 | |
| YKFPKDVDSVIIKVV | 191 | Q9NXL6 | |
| SLTKIEKVFSKLLYP | 306 | Q9P2H5 | |
| KKEEYLTFSPLTVVI | 211 | Q8TCT8 | |
| KYKTLESAFLAPAII | 51 | O95858 | |
| AKAFTIKKTLEIYVP | 2156 | Q9H5I5 | |
| VISKVLTFDLTKYPD | 1211 | Q14683 | |
| FEALKYPKFSKAIVI | 161 | Q96MV1 | |
| LEEPTVIKKYLLKVA | 256 | Q9Y5X3 | |
| TKHKIPVKYLEFISE | 96 | P02144 | |
| IVYKVQFDTKPLKFV | 426 | Q9P2E3 | |
| LSSYELKKKPVVTIY | 171 | O95789 | |
| AKSKTPYTIAETLVK | 831 | Q6R2W3 | |
| KVKFYIDVKKFPISI | 296 | Q9H598 | |
| VKVPTTLAEYCIKTK | 181 | Q712K3 | |
| KKYTKIIDGVPVEIT | 731 | Q15063 | |
| KFQPTKVLGIYTFTK | 4846 | Q5T4S7 | |
| STFHRIIPTKEKLYK | 126 | Q7Z3V5 | |
| YIETTPLTIKGKSVK | 731 | Q14966 | |
| CLSTYELKKKPIVTI | 421 | Q5VZL5 | |
| TKKYAKGVIPSSLFL | 251 | O76024 | |
| KSKNILFVITKPDVY | 1961 | E9PAV3 | |
| ELVTKLYEAAVKKVP | 96 | Q14CX7 | |
| IVFKTPKYKDINITK | 311 | P19838 |